Electrophysiologic Effects, Clinical Efficacy and Antiarrhythmic and Proarrhythmic Effects of Sodium Channel Blockers in Patients with Ventricular Tachyarrhythmias-Reference-Cited by-同舟云学术

Electrophysiologic Effects, Clinical Efficacy and Antiarrhythmic and Proarrhythmic Effects of Sodium Channel Blockers in Patients with Ventricular Tachyarrhythmias

Published:1995 Issue: Volume: Page:300-320
ISSN:
Container-title:Antiarrhythmic Drugs
language:
Short-container-title:

Author:

Shenasa M.,Haverkamp W.,Shenasa H.,Hindricks G.,Chen X.,Borggrefe M.,Breithardt G.

Publisher

Springer Berlin Heidelberg

Link

https://link.springer.com/content/pdf/10.1007/978-3-642-85624-2_16

Reference81 articles.

1. Morganroth J, Bigger JT, Anerson JL (1990) Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available. Am J Cardiol 65: 40–48

2. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology (1991) The Sicilian Gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84: 1831–1851 (Simultaneously published in Eur Heart J 12:1112–1131)

3. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406–412

4. The Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effect of the anti-arrhythmic agent moricizine on survival after myocardial infarction: N Engl J Med 327: 227–233

5. Greene HL, Roden DM, Datz RJ, Woosle RL, Salerno DM, Henthorn RW, CAST Investigators (1992) The Cardiac Arrhythmia Suppression Trial: first CAST… then CAST-II: J Am Coll Cardiol 19: 894–898